ACUTA CAPITAL PARTNERS, LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 157 filers reported holding ASCENDIS PHARMA A/S in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.7%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2020$8,208,000
+15.3%
55,500
-12.2%
2.37%
-31.3%
Q1 2020$7,117,000
+127.4%
63,200
+180.9%
3.45%
+345.2%
Q4 2019$3,130,000
-38.2%
22,500
-68.5%
0.78%
-57.1%
Q3 2018$5,066,000
-75.5%
71,500
-77.0%
1.81%
-51.0%
Q2 2018$20,695,000
-41.8%
311,111
-42.8%
3.68%
-36.6%
Q1 2018$35,578,000
+67.3%
544,000
+2.4%
5.81%
+44.7%
Q4 2017$21,272,000
+17.4%
531,000
+6.2%
4.02%
+23.6%
Q3 2017$18,125,000
-29.4%
500,000
-45.9%
3.25%
-54.8%
Q2 2017$25,664,000
+66.6%
924,483
+68.1%
7.18%
+96.7%
Q1 2017$15,400,000
+32.3%
550,000
-4.4%
3.65%
-15.7%
Q4 2016$11,644,000
+59.6%
575,309
+58.5%
4.33%
+58.1%
Q3 2016$7,296,000
+16.3%
363,000
-23.2%
2.74%
-9.2%
Q2 2016$6,274,000
-45.8%
472,800
-24.2%
3.02%
-53.4%
Q1 2016$11,568,000
+21.6%
623,631
+20.1%
6.47%
+42.2%
Q4 2015$9,513,000
+14.4%
519,243
+10.5%
4.55%
-5.5%
Q3 2015$8,317,000
+11.5%
469,893
+11.4%
4.82%
+4.4%
Q2 2015$7,458,000
+88.0%
421,851
+84.5%
4.61%
+38.1%
Q1 2015$3,966,000228,6123.34%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2020
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders